V
Valluvan Jeevanandam
Researcher at University of Chicago
Publications - 333
Citations - 12622
Valluvan Jeevanandam is an academic researcher from University of Chicago. The author has contributed to research in topics: Ventricular assist device & Transplantation. The author has an hindex of 53, co-authored 275 publications receiving 10784 citations. Previous affiliations of Valluvan Jeevanandam include Brigham and Women's Hospital & University of Kansas.
Papers
More filters
Journal ArticleDOI
A fully magnetically levitated left ventricular assist device - Final report
Mandeep R. Mehra,Nir Uriel,Yoshifumi Naka,Joseph C. Cleveland,Melana Yuzefpolskaya,Christopher T. Salerno,Mary Norine Walsh,Carmelo A. Milano,Chetan B. Patel,Steven W. Hutchins,John Ransom,Gregory A. Ewald,Akinobu Itoh,Nirav Raval,Scott C. Silvestry,Rebecca Cogswell,Ranjit John,Arvind Bhimaraj,Brian A. Bruckner,Brian D. Lowes,John Y. Um,Valluvan Jeevanandam,Gabriel Sayer,Abeel A. Mangi,Ezequiel J. Molina,Farooq H. Sheikh,Keith D. Aaronson,Francis D. Pagani,William Cotts,Antone Tatooles,Ashok N. Babu,Don Chomsky,Jason N. Katz,Paul B. Tessmann,David A. Dean,Arun Krishnamoorthy,Joyce Chuang,Ia Topuria,Poornima Sood,Daniel J. Goldstein +39 more
TL;DR: Among patients with advanced heart failure, a fully magnetically levitated centrifugal‐flow left ventricular assist device was associated with less frequent need for pump replacement than an axial‐flow device and was superior with respect to survival free of disabling stroke or reoperation to replace or remove a malfunctioning device.
Journal ArticleDOI
Use of an Intrapericardial, Continuous-Flow, Centrifugal Pump in Patients Awaiting Heart Transplantation
Keith D. Aaronson,Mark S. Slaughter,Leslie W. Miller,Edwin C. McGee,William Cotts,Michael A. Acker,Mariell Jessup,Igor D. Gregoric,Pranav Loyalka,O.H. Frazier,Valluvan Jeevanandam,Allen S. Anderson,Robert L. Kormos,Jeffrey J. Teuteberg,Wayne C. Levy,D.C. Naftel,Richard M. Bittman,Francis D. Pagani,David R. Hathaway,Steven W. Boyce +19 more
TL;DR: A small, intrapericardially positioned, continuous-flow, centrifugal pump was noninferior to contemporaneously implanted, commercially available ventricular assist devices and functional capacity and quality of life improved markedly, and the adverse event profile was favorable.
Journal ArticleDOI
Intrapericardial Left Ventricular Assist Device for Advanced Heart Failure.
Joseph G. Rogers,Francis D. Pagani,Antone Tatooles,Geetha Bhat,Mark S. Slaughter,Emma J. Birks,Steven W. Boyce,Samer S. Najjar,Valluvan Jeevanandam,Allen S. Anderson,Igor D. Gregoric,Hari R. Mallidi,Katrin Leadley,Keith D. Aaronson,O.H. Frazier,Carmelo A. Milano +15 more
TL;DR: In this trial involving patients with advanced heart failure who were ineligible for heart transplantation, a small, intrapericardial, centrifugal‐flow LVAD was found to be noninferior to an axial‐ flow LVAD with respect to survival free from disabling stroke or device removal for malfunction or failure.
Journal ArticleDOI
Two-Year Outcomes with a Magnetically Levitated Cardiac Pump in Heart Failure
Mandeep R. Mehra,Daniel J. Goldstein,Nir Uriel,Joseph C. Cleveland,Melana Yuzefpolskaya,Christopher T. Salerno,Mary Norine Walsh,Carmelo A. Milano,Chetan B. Patel,Gregory A. Ewald,Akinobu Itoh,David A. Dean,Arun Krishnamoorthy,William Cotts,Antone Tatooles,Ulrich P. Jorde,Brian A. Bruckner,Jerry D. Estep,Valluvan Jeevanandam,Gabriel Sayer,Douglas A. Horstmanshof,Douglas A. Horstmanshof,James W. Long,Sanjeev K. Gulati,Eric Skipper,John B. O'Connell,Gerald Heatley,Poornima Sood,Yoshifumi Naka +28 more
TL;DR: In patients with advanced heart failure, a fully magnetically levitated centrifugal‐flow pump was superior to a mechanical‐bearing axial‐ flow pump with regard to survival free of disabling stroke or reoperation to replace or remove a malfunctioning device.
Journal ArticleDOI
Myocyte Recovery After Mechanical Circulatory Support in Humans With End-Stage Heart Failure
Konstantina Dipla,Julian A. Mattiello,Valluvan Jeevanandam,Steven R. Houser,Kenneth B. Margulies +4 more
TL;DR: The results of the study strongly support the idea that circulatory support with an LVAD improves myocyte contractile properties and increases beta-adrenergic responsiveness.